Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abel is a women's health company specializing in personalized nutraceutical solutions for hormone balance. The company leverages a data-driven platform to provide tailored supplement regimens designed to alleviate symptoms of menopause, perimenopause, and general hormonal fluctuations. Their flagship product, Abel, is a daily supplement formulated with evidence-based ingredients to support endocrine health. Abel combines nutritional science with digital health tracking to offer a holistic approach to women's wellness. The company was founded by Dr. Karli-Jade Prior with the goal of providing a scientifically-backed alternative to generic supplements. By utilizing individual health data, Abel ensures that users receive the specific nutrients required for their unique hormonal profile.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abel Nutraceuticals.